Business
Announcement on Voluntary Disclosure of the Approval of the New Drug Marketing Application for Anmuqita Monoclonal Antibody Injection
Announcement on Voluntary Disclosure of the Approval of the New Drug Marketing Application for Anmuqita Monoclonal Antibody Injection
About this update from Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd. Class A
Announcement on Voluntary Disclosure of the Approval of the New Drug Marketing Application for Anmuqita Monoclonal Antibody Injection The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment